Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,457,771
-$1,925,735 QoQ
Shares Held
160,082
-29.1% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 95.99330343199111.ToString("F0")%
None 4.006696568008896.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. RCUS ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in RCUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,457,771 | 160,082 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,383,506 | 225,913 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,854,055 | 209,857 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,265,729 | 155,495 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,260,223 | 160,538 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $23,043,629 | 1,547,591 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,171,576 | 1,319,266 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,455,688 | 1,474,438 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,675,275 | 1,201,021 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,224,775 | 1,634,805 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,359,634 | 1,579,924 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,018,097 | 1,477,996 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,557,438 | 195,035 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $4,220,829 | 204,102 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,468,957 | 209,058 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,875,238 | 192,393 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $10,405,555 | 298,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,194,337 | 298,410 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $38,480,690 | 1,370,395 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,731,162 | 1,376,393 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||